Evaluation of Pharmacodynamic Interactions Between Telavancin and Aztreonam or Piperacillin/Tazobactam Against Pseudomonas aeruginosa, Escherichia coli and Methicillin-Resistant Staphylococcus aureus.

Yim, Juwon; Smith, Jordan R; Barber, Katie E; Hallesy, Jessica A; Rybak, Michael J

Yim, Juwon; Smith, Jordan R; Barber, Katie E; Hallesy, Jessica A; Rybak, Michael J.

Afiliación

Yim J; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Ave., Detroit, MI, 48201, USA.
Smith JR; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Ave., Detroit, MI, 48201, USA.
Barber KE; School of Pharmacy, The University of Mississippi, 2500 North State Street, Jackson, MS, 39216, USA.
Hallesy JA; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Ave., Detroit, MI, 48201, USA.
Rybak MJ; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Ave., Detroit, MI, 48201, USA. m.rybak@wayne.edu.

Infect Dis Ther ; 5(3): 367-77, 2016 Sep.

Article en En | MEDLINE | ID: mdl-27432414

Palabras clave

Aztreonam; Drug interactions; Escherichia coli; Methicillin resistant; Piperacillin/tazobactam; Pseudomonas aeruginosa; Staphylococcus aureus; Telavancin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Infect Dis Ther Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google